Cargando…
Blood draws up to 3% of blood volume in clinical trials are safe in children
AIM: Recommendations for maximum blood draw in children range from 1 to 5% despite limited evidence. The aim of the study was to assess the safety of blood draws in children aged six months to 12 years targeting volumes of 3% of total blood volume. METHODS: Children who experienced three‐monthly blo...
Autores principales: | Peplow, Claudia, Assfalg, Robin, Beyerlein, Andreas, Hasford, Joerg, Bonifacio, Ezio, Ziegler, Anette‐G |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6587985/ https://www.ncbi.nlm.nih.gov/pubmed/30291644 http://dx.doi.org/10.1111/apa.14607 |
Ejemplares similares
-
Capillary blood islet autoantibody screening for identifying pre-type 1 diabetes in the general population: design and initial results of the Fr1da study
por: Raab, Jennifer, et al.
Publicado: (2016) -
Efficacy of vildagliptin for prevention of postpartum diabetes in women with a recent history of insulin-requiring gestational diabetes: A phase II, randomized, double-blind, placebo-controlled study
por: Hummel, Sandra, et al.
Publicado: (2018) -
Oral insulin immunotherapy in children at risk for type 1 diabetes in a randomised controlled trial
por: Assfalg, Robin, et al.
Publicado: (2021) -
Blood pressure reduction, persistence and costs in the evaluation of antihypertensive drug treatment – a review
por: Bramlage, Peter, et al.
Publicado: (2009) -
Why is the presence of autoantibodies against GAD associated with a relatively slow progression to clinical diabetes?
por: Ziegler, Anette-Gabriele, et al.
Publicado: (2020)